Jeremy Sarich

PharmD, RPh, MBA

Senior Consultant

San Diego, CA, US

Jeremy Sarich is a senior consulting pharmacist with the San Diego office of Milliman. He joined the firm in 2022 and has been working in the pharmacy industry since 2001.

Download bio

Loading component...

Experience

Jeremy has more than 18 years of pharmacy benefit management (PBM) experience. He has a robust and in-depth understanding of the payer environment for employers, coalitions, union funds, health systems, public sector entities, Medicare, and Medicaid lines of business, and is a proven collaborator with both internal and external partners. In his current role, Jeremy is responsible for providing consultative solutions for his clients, ensuring they meet their clinical and financial goals and objectives. He supports overall strategy development and implementation, contracting, clinical information, trend management, network strategy, vendor transitions, and operations. Jeremy’s experience includes:

340B
Auditing
Benefit design
Benefit operations management
Clinical strategy
Contracting
Cost analysis
Drug information
Healthcare reform
Implementation
Strategic planning
Vendor selection

Professional Designations

Registered Pharmacist, Nebraska Board of Pharmacy

Education

BS, Biology, University Nebraska at Omaha
PharmD (with Honors), Creighton University
MBA, Creighton University

Loading component...

Publications

Read their latest work

Article

Building a long-range GLP-1 forecast: When could commercial health plans see a plateau?

11 September 2025 - by John Rogers, Liam Kussman, Brian Anderson, Jeremy Sarich, Andrew Marshall

GLP-1 drugs: We provide a framework for building a long-range forecast to help employers understand how trends may change over time.

Video

Midnight approaches: Reactions to Part D reforms

20 March 2024 - by Jeremy Sarich, John Rogers, Les Kartchner, Michelle (Klein) Robb

As midnight on June 3 approaches, many plans face considerable uncertainties relating to the Inflation Reduction Act’s benefit redesign, Medicare Prescription Payment Plan, and changes from the Advance Notice.

Jeremy Sarich

Loading component...

Experience

Loading component...

Read their latest work

Building a long-range GLP-1 forecast: When could commercial health plans see a plateau?

Midnight approaches: Reactions to Part D reforms

CHOOSE A LOCATION AND LANGUAGE

Jeremy Sarich

Experience

CHOOSE A LOCATION AND LANGUAGE